Corporate News     22-Aug-23
Marksans Pharma receives USFDA approval for Guaifenesin ER Tablets
Marksans Pharma announced that it has received final approval from the US Food and Drug Administration (“FDA”) for its Abbreviated New Drug Application (ANDA) for Guaifenesin Extended-Release Tablets, 600 mg and 1200 mg (OTC) The Guaifenesin Extended-Release Tablets, 600 mg and 1200 mg (OTC) are bioequivalent to the reference listed drug (RLD), Mucinex Extended-Release Tablets, 600 mg and 1200 mg, of RB Health (US) LLC.

Guaifenesin extended-release tablets help to loosen phlegm (mucus) and thin bronchial secretions to rid the bronchial passageways of bothersome mucus and make coughs more productive. The company expects to launch the product immediately.

Previous News
  Marksans Pharma standalone net profit declines 22.22% in the September 2023 quarter
 ( Results - Announcements 09-Nov-23   14:28 )
  Marksans arm receives UK MHRA marketing authorisation for Cyanocobalamin 50mg film coated tablet
 ( Corporate News - 06-Nov-23   18:30 )
  Marksans Pharma consolidated net profit rises 36.36% in the September 2023 quarter
 ( Results - Announcements 09-Nov-23   15:15 )
  Marksans Pharma gains on US FDA nod for Cetirizine Hydrochloride tablets
 ( Hot Pursuit - 11-Jan-22   15:32 )
  Marksans Pharma completes acquisition of Teva's manufacturing unit in Goa
 ( Corporate News - 19-Apr-23   11:40 )
  Marksans Pharma consolidated net profit rises 26.80% in the June 2021 quarter
 ( Results - Announcements 11-Aug-21   17:29 )
  Marksans Pharma corrects on profit booking
 ( Hot Pursuit - 22-Feb-17   10:29 )
  Marksans Pharma receives upgrade in credit ratings
 ( Corporate News - 08-Dec-23   16:03 )
  Marksans Pharma to conduct board meeting
 ( Corporate News - 18-May-23   15:47 )
  Marksans Pharma gains on acquiring manufacturing facility from Tevapharm India
 ( Hot Pursuit - 19-Apr-23   12:07 )
  Marksans Pharma gets UK MHRA approval for Fluoxetine oral solution
 ( Hot Pursuit - 23-Jan-23   13:30 )
Other Stories
  Share India Securities allots 16.92 lakh equity shares on conversion of warrants
  06-Jul-24   13:11
  Tinna Trade raises Rs 49 cr to fund its growth plans
  06-Jul-24   11:10
  Integra Essentia announces merger with G G Engineering
  06-Jul-24   11:05
  Ugro Capital to raise Rs 75 cr via NCD issuance
  06-Jul-24   10:58
  Board of D.P. Abhushan approves preferential allotment of shares and warrants
  06-Jul-24   10:50
  Life Insurance Corporation of India invest Rs 14 cr in Sri Lankan subsidiary
  06-Jul-24   10:49
  High Energy Batteries (India) to discuss results
  06-Jul-24   10:29
  Havells India schedules board meeting
  06-Jul-24   10:29
  Axis Bank announces board meeting date
  06-Jul-24   10:29
  Mastek to conduct board meeting
  06-Jul-24   10:29
Back Top